2021
DOI: 10.1016/j.jvir.2020.08.019
|View full text |Cite
|
Sign up to set email alerts
|

Mechanochemical Endovenous Ablation of Varicose Veins in Pediatric Patients with Klippel-Trénaunay Syndrome: Feasibility, Safety, and Initial Results

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 18 publications
0
3
0
Order By: Relevance
“…61 The MOCA technique has a dual mechanism: a rotating wire tip provides mechanical damage to the endothelium and the sclerosing agent causes chemical damage. 62 In a prospective study of 13 MOCA procedures on 11 patients, Lambert et al demonstrated that primary occlusion without any adverse events were achieved by this technique with partial recanalization and symptom recurrence only occurring in 2 of 11 patients (18%) at 14- and 18-month follow-up. These patients would undergo a second MOCA procedure without any recanalization or symptom recurrence during their next follow-up period.…”
Section: Molecular Therapiesmentioning
confidence: 97%
See 1 more Smart Citation
“…61 The MOCA technique has a dual mechanism: a rotating wire tip provides mechanical damage to the endothelium and the sclerosing agent causes chemical damage. 62 In a prospective study of 13 MOCA procedures on 11 patients, Lambert et al demonstrated that primary occlusion without any adverse events were achieved by this technique with partial recanalization and symptom recurrence only occurring in 2 of 11 patients (18%) at 14- and 18-month follow-up. These patients would undergo a second MOCA procedure without any recanalization or symptom recurrence during their next follow-up period.…”
Section: Molecular Therapiesmentioning
confidence: 97%
“…These patients would undergo a second MOCA procedure without any recanalization or symptom recurrence during their next follow-up period. 62…”
Section: Molecular Therapiesmentioning
confidence: 99%
“…Newer modalities of endovenous ablations include a catheter-based viscous glue (VenaSeal; Medtronic, Minneapolis, MN) and pharmacomechanical device that employs motorized endovenous stripping (ClariVein; Merit, South Jordan, UT). 45,46 Although the experience with these devices for VM is new, the potential advantages of these systems are the lack of thermal injury and decreased need for tumescence.…”
Section: Endovenous Ablationmentioning
confidence: 99%